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Abstract
Schizophrenia spectrum disorder (SZ) is associated with deficits in auditory perception as well as 
auditory verbal hallucinations (AVH). However, the relationship between auditory feature 
perception and auditory verbal hallucinations (AVH), one of the most commonly occurring 
symptoms in psychosis, has not been well characterized. This study evaluated perception of a 
broad range of auditory features in SZ and to determine whether current AVHs relate to auditory 
feature perception. Auditory perception, including frequency, intensity, duration, pulse-train and 
temporal order discrimination, as well as an embedded tone task, was assessed in both AVH (n = 
20) and non-AVH (n = 24) SZ individuals and in healthy controls (n = 29) with the Test of Basic 
Auditory Capabilities (TBAC). The Hamilton Program for Schizophrenia Voices Questionnaire 
(HPSVQ) was used to assess the experience of auditory hallucinations in patients with SZ. 
Findings suggest that compared to controls, the SZ group had greater deficits on an array of 
auditory features, with non-AVH SZ individuals showing the most severe degree of abnormality. 
IQ and measures of cognitive processing were positively associated with performance on the 
TBAC for all SZ individuals, but not with the HPSVQ scores. These findings indicate that persons 
with SZ demonstrate impaired auditory perception for a broad range of features. It does not appear 
that impaired auditory perception is associated with recent auditory verbal hallucinations, but 
instead associated with the degree of intellectual impairment in SZ.
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Introduction
Behavioral investigations of auditory perception in individuals with schizophrenia spectrum 
disorders (SZ) have shown deficits in tone matching on the basis of pitch [1–3]. A recent 
meta-analysis by Dondé et al. (2016) lends support to the individual studies reviewed in that 
the meta-analysis yielded a large effect size (standardized mean difference =1.17, [95% CI 
0.926–1.418]) for the comparison of individuals with schizophrenia and healthy controls on 
pitch discrimination performance for non-verbal sounds [4]. These behavioral findings are 
consistent with auditory event-related potential deficits as well as neuroanatomical 
abnormalities affecting the auditory cortex [5].
Deficits in basic auditory processing can impact higher levels of cognition [6,5]. Moreover, 
degradation of sensory input has been associated with hallucinations in psychologically 
healthy people. For example, Cole et al. (2002) reported that 33% of an elderly sample 
referred to an audiology clinic for assessment of hearing impairment experienced auditory 
hallucinations [7]. Consequently, auditory perceptual deficits could contribute to 
hallucinatory experiences in persons with psychosis as well. Auditory verbal hallucinations 
(AVH) are reported by approximately 75% of individuals with the illness [8,9]. There have 
been few studies on the relationship between AVH and auditory perception, and have led to 
mixed results. An inverse relationship [10], as well as no relationship [11], has been 
observed between tone matching ability and positive symptoms. In a specific assessment of 
auditory hallucinations, SZ individuals with auditory hallucinations have been observed to 
perform worse than non-AVH peers on a task of pitch discrimination [12].
While the experience and subjective interpretation of AVHs undoubtedly involves many 
brain processes, such as deficits in memory operations, self-monitoring or interhemispheric 
miscommunication [13,8,5], the possible role of auditory perceptual deficits warrants 
detailed investigation. This study therefore had three aims. First, we tested whether patients 
with SZ showed impairments on discrimination of specific auditory features, or a more 
pervasive impairment of auditory processing using a well validated instrument, the Test of 
Basic Auditory Capabilities (TBAC)[14]. Secondly, we tested whether SZ patients who 
reported recent auditory hallucinations showed impaired auditory perception compared to 
those who did not. Finally, we tested whether more severe auditory hallucinations or more 
impaired cognitions would be associated with more impaired auditory perception in persons 
with SZs.
Methods
Subjects
Forty-four medicated SZ subjects (31 male) and twenty-nine healthy controls (14 male) were 
evaluated. SZ subjects were recruited through outpatient units at community and state 
hospitals. Healthy, non-psychiatric control subjects were recruited from the community via 
local and on-line advertisements. After detailed explanation of research procedures, subjects 
provided verbal and written informed consent. Study procedures were executed as approved 
by the Indiana University Institutional Review Board, and carried out according to 
guidelines of the Declaration of Helsinki.
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SZ diagnoses were determined using the Structured Clinical Interview for Axis-I disorders 
(SCID-I, patient edition; [15]), symptom assessment, clinical observation and medical chart 
review. Subjects in the AVH group included all SZ subjects who self-reported experiencing 
AVHs in the week prior to study participation. All other SZ subjects, who did not endorse 
recent (one week) AVHs were in the Non-AVH group. SZ subjects were excluded if they met 
criteria as per the SCID-I for substance abuse or dependence over the previous 3 months, or 
evidence of positive urine toxicology at the time of screening.
Control participants were interviewed using the SCID-NP (nonpatient edition; [16]) to 
exclude individuals with psychiatric diagnoses including substance abuse or dependence 
(excluding nicotine), if they had a positive urine toxicology at the time of screening, or if 
they had a family history of an Axis-I psychiatric disorder. All subjects were excluded from 
participation if they had a lifetime serious head injury with a loss of consciousness greater 
than 5 minutes, a neurological disorder, or hearing deficits (as per a screening audiogram). 
All participants were at least 18 years of age.
Assessments
Auditory feature discrimination was assessed with the test of basic auditory capabilities 
(TBAC)[14]. The TBAC tests assessed the ability to detect a change in a single tone 
(frequency, intensity, and duration) as well as changes in sequences of tones. The measures 
with tone sequences were 1) pulse train; discrimination of a change in the relative timing of 
tone onsets in a sequence of six brief tones (i.e., rhythm), 2) temporal order; changes in the 
temporal order of the middle two tones in a four-tone sequence, and 3) embedded tone 
detection; detection of the presence of a tone (or a silent pause) in the middle of a sequence 
of nine (or eight) brief tones. All measures used a standard/two-alternative forced choice 
procedure in which a standard stimulus (tone or sequence) was followed by two stimuli, one 
of which was identical to the standard. The listener’s task was to judge which comparison 
was different from the standard. For all TBAC tasks, performance is measured as percent 
correct for a sequence of trials varying in difficulty.
Auditory hallucinations were characterized with the Hamilton Program for Schizophrenia 
Voices Questionnaire (HPSVQ)[17]. If subjects reported hearing voices over the week prior 
to testing, subjects were asked to complete the HPSVQ which assess the subjective 
experience of voice hearing, asking questions regarding frequency and intensity of the 
voices, as well as feeling distress from the voices, feelings of worthlessness/uselessness 
from the voices, as well as addressing how often subjects follow the commands of the 
voices. The total HSPVQ is based on a series of 9 HPSVQ questions and a higher score is 
indicative of more severe auditory hallucinations. Two factors evaluating distress and 
intensity were calculated from the HPSVQ items for the correlational analysis, as per 
previous literature [18]. If subjects denied AVHs over the previous week, the HPSVQ was 
not administered as the questions related only to auditory voice hearing experiences over the 
past week. The Positive and Negative Syndrome Scale (PANSS) [19] was used to measure 
positive, negative and general symptoms in patients. The Full-scale intelligence quotient 
(IQ) was assessed with the Wechsler Abbreviated Scale of Intelligence (WASI) [20]. 
Working memory and capacity for psychomotor performance were assessed using the Digit 
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Span and Digit Symbol scaled scores, respectively, from the Wechsler Adult Intelligence 
Scale III (WAIS III) [21].
Statistical analysis
All statistical analyses were executed with SPSS statistical software from IBM [22]. Groups 
were first evaluated for differences in age, education, and age of psychosis onset (SZ groups) 
with a Student’s t-test. Differences in ethnicity and gender were then determined using the 
computation of Chi-square. Demographic information is indicated in means ± standard 
deviation (SD), unless otherwise indicated. Next, to determine general group differences 
between the SZ and control groups on the six domains of the TBA, as well as group 
differences based on voice hearing experience a multivariate analysis of variance 
(MANOVA) was used. If significant, groups were compared with post-hoc comparisons with 
the Tukey HSD correction. An additional MANOVA was used to determine group 
differences between the SZ and control groups on measures of cognition, including IQ, as 
well as the digit span and digit symbol tasks. If significant, groups were compared with t-
tests. In all MANOVAs Levene’s Test for equality of variances was applied to assess the 
homogeneity of variance. T-tests were used to detect group differences between the AVH 
and Non-AVH groups on symptom domains of the PANSS (positive, negative, general, and 
total). All t-tests used in the analysis were two-tailed. Effect sizes were measured with 
Cohen’s d for comparisons between the SZ and control groups, and when comparisons were 
made between AVH, non-AVH and control groups, partial eta squared was used. Finally, 
Pearson correlations were used to examine relationships between the TBAC, HPSVQ, 
PANSS, and cognitive measures.
Results
Demographic characteristics
Thirty-seven subjects in the SZ group met diagnostic criteria for Schizophrenia (AVH = 18; 
Non-AVH = 19) and seven for Schizoaffective Disorder (AVH = 2; Non-AVH = 5). The SZ 
and control groups were on average 37.07 ± 11.52 and 33.55 ± 10.75 years old, respectively. 
All subjects in the SZ group, with the exception of four individuals, had experienced 
auditory verbal hallucinations over the course of their lifetime, as per the SCID and chart 
review. Twenty of the 44 SZ individuals reported hearing voices during the week prior to 
testing (14 male). The AVH and Non-AVH groups were on average 37.25 ± 13.27 and 36.92 
± 10.13 years old, respectively. Groups (SZ, Controls, AVH SZs and Non-AVH SZs) did not 
differ significantly in age or gender (p > .05). Demographic information and clinical 
assessment measures with means and standard deviations are shown in Table 1. Most 
patients (39/44) were receiving anti-psychotic medication. Medication records at the time of 
testing for the SZ group are listed in Table 2.
Auditory feature discrimination in SZ
The SZ group demonstrated a deficit in performance on all domains of the TBAC compared 
to the control group, with the exception of pulse-train discrimination (Figure 1). A 
MANOVA revealed a significant multivariate main effect of group, Roy’s Largest Root 
= .269, F(6,66) = 2.96, p =.013, and partial eta squared =.212. Given the significance of the 
Martin et al. Page 4
Eur Arch Psychiatry Clin Neurosci. Author manuscript; available in PMC 2020 April 04.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
overall test, post-hoc testing using Tukey’s test as a correction for multiple comparisons was 
to determine which of the six domains of the TBAC domains differed between the groups. 
Results indicated that there was a significant difference between the groups (p <.05) on 
frequency (p = .010, mean difference = 7.97, d = .64), intensity (p = .021, mean difference = 
9.16, d = .56), duration (p = .003, mean difference = 10.39, d = .75), embedded tone test (p 
= .001, mean difference = 12.83, d = .83) and temporal order discrimination (p = .004, mean 
difference = 8.77, d = .70). Groups did not differ on the pulse-train discrimination domain (p 
= .093, mean difference = 6.66, d = .41). The control group scored higher on all six domains 
of the TBAC. Thus, SZ was associated with a pervasive disturbance of auditory feature 
perception, rather than deficits for specific features.
Group differences on TBAC based on voice hearing experience
Compared to controls, the non-AVH group showed more severe deficits on the TBAC 
compared to their SZ peers who reported recent AVHs (Figure 2). A MANOVA revealed a 
significant multivariate main effect of group, Roy’s Largest Root = .269, F(6,66) = 2.96, p 
=.013, and partial eta squared =.212. Given the significance of the overall test, between-
subject effects were evaluated to determine which of the six domains of the TBAC domains 
differed between the groups.
Tests of between-subjects effects indicated differences on the TBAC for all domains except 
the intensity and pulse-train discrimination tasks. Specifically, group differences were 
observed on tests of frequency (F(2, 70) = 3.68, p =.030, partial eta squared = .10) and 
duration (F(2,70)=4.84, p = .011, partial eta squared = .12) discrimination, on the embedded 
tone test (F(2,70) = 6.47, p = .003, partial eta squared = .16) and for temporal order 
discrimination (F(2,70) = 4.31, p = .017, partial eta squared = .11). There was a trend for 
group differences on the intensity discrimination test (F(2,70)=2.92, p = .061, partial eta 
squared = .08) and pulse-train discrimination (F(2,70) = 2.05, p = .14, partial eta squared 
= .06).
Post-hoc multiple comparisons with Tukey HSD correction indicated that the Non-AVH 
group was more consistently impaired on TBAC tests compared to the AVH group. The non-
AVH SZ showed a deficit compared to the control group on frequency (p= .031; mean 
difference = 9.00), duration (p= .025; mean difference = 10.31), embedded tone test 
(p= .003; mean difference = 14.80) and temporal order discrimination (p = .024; mean 
difference = 9.32). There was also a trend towards a significance difference on the domain of 
intensity discrimination between the non-AVH group and controls (p = .059; mean 
difference = 10.49). The only observed significant difference between the AVH SZ and 
control groups were deficits in the AVH SZ group on duration discrimination (p = .031; 
mean difference = 10.49). There were also trends towards significant differences between 
these groups, with deficits observed in the AVH SZ group, on the embedded tone test (p 
= .058; mean difference = 10.47) as well as temporal order discrimination (p = .075; mean 
difference = 8.09). The AVH and non-AVH groups did not differ on any of the TBAC tests. 
See Table 3 for details of TBAC performance with percent correct and standard deviation by 
group.
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Group differences on cognitive measures
Overall, group differences were observed between the SZ and control groups on measures of 
IQ and the Digit Symbol task (Table 1). A MANOVA determined a significant main effect of 
group (2 levels: SZ and control), Roy’s Largest Root = .488, F(3,69) = 11.22, p < .001, and 
partial eta squared =.328. Given the significance of the overall test, post-hoc t-tests were 
used to determine SZ and control group differences. The SZ group showed a significant 
deficit in IQ (t(71) = 4.003, p < .001, d = .96), and on the digit symbol task (t(46.40) = 5.03, 
p < .001, d = 1.29), but not on the digit span task (t(71)= 1.22, p = .228, d = .29).
Group differences in symptoms
Group means and SDs for the PANNS factor scores are shown in Table 1. The AVH group 
showed higher PANSS positive symptom (t(42)=−2.34, p = .024, d = .71) and general 
symptom scores (t(27.93)=−2.11, p = .044, d = .67) compared to the non-AVH group. The 
groups did not statistically differ in negative symptoms scores (t(42)= .99, p = .328, d = .30) 
or total scores (t(42)= −1.81, p = .077, d = .55).
Correlations
Across all SZ participants (Table 4) measures of the TBAC were highly intercorrelated 
(r= .4-.8; p < .05). PANSS total scores were observed to negatively correlate with frequency 
discrimination (r = −.31, p = .042) and temporal order discrimination (r = −.31, p =.044). 
Temporal order discrimination was also observed to be negatively associated with PANSS 
negative domain scores (r = −.30, p .05). With respect to cognitive measures, IQ was 
observed to positively correlate with all measures of the TBAC, including frequency (r(n = 
44) = .55, p < .001), intensity (r = .57, p <.001), duration (r = .41, p = .006), pulse-train (r 
= .54, p <.001), and temporal order discrimination (r = .59, p <.001), as well as the 
embedded tone test (r = .55, p < .001). The digit symbol was positively associated with 
frequency (r = .31, p =.038), pulse-train (r = .39, p =.010), and temporal order discrimination 
(r = .34, p = .025). Digit span failed to significantly correlate with any TBAC measure (p 
>.05). In controls, all measures of the TBAC were significantly correlated with IQ for 
healthy controls (p < .05, r = .45 - .57).
For those in the AVH SZ group (Table 4), none of the six domains of the TBAC correlated 
with either factor of the HPSVQ (distress or intensity) (p >.05). PANSS negative symptoms 
were negatively associated with the HPSVQ factor of distress (r(n = 20) = −.48, p = .034) as 
well as with frequency (r = −.60, p = .005), and pulse-train discrimination (r = −.58, p 
= .008) measures from the TBAC. PANSS positive scores were positively associated with 
the HPSVQ factor of intensity (r = .50, p = .025), but were not observed to be significantly 
associated with any of the six domains of the TBAC. PANSS general scores were also 
negatively associated with intensity discrimination (r = −.60, p =.006) of the TBAC.
Discussion
This study demonstrates that persons with SZ are impaired in the discrimination of a broad 
range of auditory features, consistent with our hypothesis. Contrary to our initial hypothesis, 
however, the non-AVH SZ individuals were observed to have the more pronounced deficits 
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in auditory perception compared to controls, than their AVH SZ peers. Auditory perceptual 
performance instead was correlated with overall intellectual function.
The SZ group demonstrated deficits in auditory perception for single auditory features 
(frequency, intensity and duration) as well as more complex stimulus properties, such as 
temporal order. In a factor analysis by Kidd et al. (2007), these tests loaded most strongly on 
the loudness-duration factor and pitch and time factor of the entire set of TBAC tests [14]. 
The results are consistent with a recent meta-analysis of pitch discrimination deficits [4], as 
our study yielded medium to large effect sizes for discrimination tasks on frequency, 
intensity, duration and temporal order, as well as the embedded tone task (Cohen’s d = .56 
- .83). These findings suggest that impaired processing of non-speech sounds is relatively 
non-specific to a specific feature or category. Since previous studies have generally focused 
on a single domain of auditory feature perception, especially pitch or frequency 
discrimination, these data implicate a broad spectrum of dysfunction in the perceptual 
domain. This conclusion is also supported by the wide range of deficits across studies of SZ, 
including impaired in duration [23] intensity [24], phoneme [25] and sound location [26] 
discrimination, as well as detection of abnormal melodies on the Distorted Tunes Task [27].
The entire set of TBAC scores were robustly correlated with IQ scores, suggesting that these 
deficits are driven by a general deficit in task performance in schizophrenia. To our 
knowledge, this is the first study to examine the relationship of auditory perceptual 
performance to standard tests of IQ in SZ subjects. In schizophrenia, deficits on tasks of tone 
matching have been related to deficits in encoding of information [28,29] and more impaired 
spatial discrimination and localization have been associated with more severe cognitive 
symptoms on the PANSS [26]. These findings are consistent with the argument by Javitt 
(2009) that sensory deficits may negatively impact cognitive processes [6]. It is important to 
acknowledge that in healthy controls, general intellectual capacity, as measured by SAT 
scores, was determined to account for less than 5% of the variance in performance on the 
TBAC [14].
Given that the current study and previous research indicate that SZ is associated with 
impairment on a wide range of auditory tasks, it was somewhat surprising that our voice 
hearing group was less severely affected than the voice hearing group compared to the 
controls. Similarly, Perrin et al. (2010) found that greater severity of hallucinations was 
associated with better accuracy on a sound localization task in SZ patients [26]. On the other 
hand, a lack of a relationship between auditory discrimination and the presence or absence 
of auditory hallucinations has been found by some investigators [25] or superiority for 
patients with no hallucinations [12]. These heterogeneous results may reflect the variety of 
neurobiological mechanisms and responses to treatment which modulate the experience of 
hallucinations [30,13]. There has also been substantial methodological variation among 
studies, such as the method of assessment of hallucinatory experiences and the time frame 
over which these were evaluated. For instance, the study by McLachlan et al. (2013) 
reported that individuals with schizophrenia and a history of auditory hallucinations 
performed worse on tasks of pitch discrimination, compared to non-hallucinating peers [12]. 
While these findings initially appear in contrast to our study, the use of different operational 
definitions to explore auditory hallucinations makes direct comparison of results difficult. 
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McLachlan et al. classified groups based on those with and without a history of auditory 
hallucinations in the past 10 weeks, who experienced intermittent auditory hallucinations 
throughout illness even while taking medication, or who experienced auditory hallucinations 
at the start of their illness which occurred within the past two years. Our study, explored 
recent AVH experience, as defined by occurrence within the past week. Therefore, given the 
difference in group inclusion definitions, it is plausible that at least some subjects in 
McLachlan’s hallucinatory group would have been considered in the non-AVH group using 
our study criteria. These methodological inconsistencies support the need for further 
investigation using more granular temporal assessment of current and past history of AVHs.
Additionally, the AVH SZ group also showed a significant deficit in duration discrimination, 
as compared to controls. It is important to consider that duration discrimination may also 
represent, in additional to basic feature detection, a perceptual timing task. In this light, it is 
important to denote that both SZ groups performed significantly worse than controls and 
thus recent AVH experience may be independent of timing perception. A caveat to this, 
however, is that the AVH group did not perform significantly worse on the temporal order 
task, which could also be considered a perceptual timing task. It will be important for future 
research to investigate the relationship between AVH and experience of time.
There are several limitations to this study which should motivate future research. Whether 
subjects experienced AVHs during testing was not evaluated and this might impact auditory 
perception. Studying AVH in SZ comes with inherent limitations associated with this 
population. SZ individuals vary in current and past medications, duration of illness, 
symptom expression, substance use, and other comorbid diagnoses. Such factors hinder the 
unambiguous interpretation of relationships between symptoms and perceptual measures. 
The findings of this study therefore need to be replicated in independent samples using 
similar inclusion criteria. Studies of relatives and persons at high risk for SZ could clarify 
whether auditory perceptual deficits are related to genetic risk or predate the onset of the 
initial psychotic episode. Tucker et al (2013), for example, found that relatives of persons 
with SZ showed deficits for tone duration discrimination, but not pitch discrimination, 
suggesting that features may differ in their sensitivity to genetic or other familial risk factors 
[31]. Other behavioral studies of auditory perception in SZ individuals with AVHs have 
utilized dichotic listening tasks, finding that AVHs were associated with a decrease in the 
traditionally observed right ear advantage, which investigators suggested may indicate left 
primary auditory cortex dysfunction with increased severity of hallucinations [32,33]. Future 
research should thus consider the role of differences in hemispheric processing.
In conclusion, this study makes several contributions to the characterization of auditory 
perception and hallucinations in schizophrenia. First, it indicates that persons with SZ show 
deficits in the perception of a broad range of auditory features. Second, the data suggest that 
it is unlikely that these auditory perceptual deficits play a major role in the experience of 
current auditory hallucinations. Rather, auditory perceptual deficits are strongly associated 
with overall cognition, and support the hypothesis that degradation of sensory input may 
disrupt subsequent cognitive processing.
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Figure 1: Primary Group Differences on the TBAC.
The dark and light gray bars represent the control and SZ groups, respectively. The asterisk 
(*) denotes significant differences between the groups (p <.05).
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Figure 2: AVH vs Non-AVH Group Differences on TBAC.
The dark medium, and light gray bars represent the control, Non-AVH and AVH SSD 
groups, respectively. The asterisk (*) denotes significant differences between the control and 
Non-AVH SZ groups (p <.05), and a solid diamond (♦) represents a significant difference 
between the control and AVH SZ groups (p <.05).
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Table 1:
Demographic Information
Control Group 
(1) SZ Group (2) AVH Group (3)
Non-AVH Group 
(4)
Significant Differences 
(<.05)
N 29 44 20 24 .
Gender (M:F) 14:15 31:13 14:6 17:7 .
Age (Range;SD) 33.55 (20–55; 10.75)
37.07 (19–59; 
11.52)
37.25 (19–59; 
13.27) 36.92 (22–53; 10.13) .
Ethnicity (C: AA: A: 
O) 15:14:0:0 15:26:1:2 5:13:0:2 10:13:1:0 .
Age Psychosis Onset . 22.93 (9.36) 20.94 (9.67) 24.64 (8.95) .
Years Education 15.93 (2.59) 12.74 (2.51) 12.45 (2.63) 13.00 (2.43) 1 > 2, 3, 4
IQ 110.55 (13.11) 96.77 (15.17) 96.90 (16.98) 96.67 (13.85) 1 > 2, 3,4
Digit Span 11.21 (2.55) 10.30 (3.45) 9.75 (3.02) 10.75 (3.78) .
Digit Symbol 11.07 (3.18) 7.64 (2.26) 7.40 (2.35) 7.83 (2.22) 1 > 2, 3, 4
PANSS Positive . 16.45 (5.82) 18.60 (6.18) 14.67 (4.96) 3 > 4
PANSS Negative . 14.81 (5.61) 13.90 (5.54) 15.58 (5.67) .
PANSS General . 31.05 (14.01) 33.90 (9.97) 28.67 (5.36) 3 > 4
PANSS Total . 62.32 (14.01) 66.40 (17.22) 58.91 (9.78) .
Note: M = Male; F = Female; (Standard Deviation); SD = Standard Deviation; C: Caucasian; AA: African American; A: Asian; O: Other
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Table 2:
Medication Information for SZ Group
Group
Medication AVH Non-AVH
Atypical antipsychotic 18 18
Typical antipsychotic 3 1
Lithium 2 1
Benzodiazepine 1 0
Antidepressant 11 9
Anticonvulsant 0 4
Anticholinergic 1 2
Stimulant 1 2
Total unmedicated 4 1
Total medicated 16 23
Total unknown 0 0
Note: AVH = Auditory Verbal Hallucinations
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Table 3:
TBAC Performance
Control Group (1) SZ Group (2) AVH Group (3) Non-AVH Group (4) Significant Differences (<.05)
Frequency Discrimination 77.35 (12.25) 69.38 (12.72) 70.62 (14.01) 68.35 (11.74) 1 > 2, 4
Intensity Discrimination 82.71 (12.65) 73.54 (18.25) 75.14 (19.67) 72.22 (17.30) 1 > 2
Duration Discrimination 75.48 (14.29) 65.08 (13.59) 64.99 (14.11) 65.16 (13.44) 1 > 2, 3, 4
Pulse-Train 
Discrimination 78.79 (15.59) 72.13 (16.83) 75.07 (16.79) 69.68 (16.83) 1 > 4
Embedded Tone Task 81.17 (13.06) 68.34 (16.78) 70.70 (17.79) 66.37 (15.99) 1 > 2, 4
Temporal Order 
Discrimination 69.62 (11.58) 60.86 (13.03) 61.53 (15.27) 60.30 (11.14) 1 > 2, 4
Note: (Standard Deviation)
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Table 4:
Correlations with TBAC Domains and HPSVQ
1 2 3 4 5 6 PANSS Positive
PANSS 
Negative
PANSS 
General IQ
Digit 
Symbol
Digit 
Span
1 Frequency 1
.77** .52** .82** .76** .72** −.28 −.17 −.22 .55** .31* .21
2 Intensity 1
.68** .80** .84** .74** −.19 −.11 −.28 .57** .26 .26
3 Duration 1
.44* .57** .63** −.17 −.08 −.23 .41* .14 .10
4 Pulse-Train 1
.82** .72** −.11 −.28 −.16 .54** .39* .29
5 Embedded Tone 1 .74** −.05 −.24 −.16 .55** .25 .29
6 Temporal Order 1 −.07 −.30* −.27 .59** .34* .26
† HPSVQ Distress .13 −.16 −.10 .13 −.14 .15 −.05 −.48* −.03 .15 .26 .23
† HPSVQ Intensity
−.
21 −.28 −.20 −.15 −.05 .05 .50* −.03 .16 −.12 .03 −.02
Note:
**p <.001;
*p <. 05;
†=AVH SZ group only (n = 20);
HPSVQ = Hamilton Program for Schizophrenia Voices Questionnaire
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